コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 t correlation was found between symptoms and gastric motility.
2 f the vago-vagal reflex circuitry regulating gastric motility.
3 omach of a patient with significantly slowed gastric motility.
4 al pre-motor neurons in the DMV that control gastric motility.
5 r (mu, delta, and kappa) stimulation affects gastric motility.
6 reduced chylous lymph-induced inhibition of gastric motility.
7 more potent than control lymph in inhibiting gastric motility.
8 ay be responsible for oesophageal control of gastric motility.
9 gastrin release, gastric acid secretion, and gastric motility.
10 ich may be prostaglandin dependent, inhibits gastric motility.
11 ric-NST or -DMN neuron responsiveness, or on gastric motility.
12 nsulin or central 2-DG causes an increase in gastric motility.
13 jects, including satiety or satiation (21%), gastric motility (14%), psychological factors (13%), and
15 ) the pathway mediating reflex inhibition of gastric motility and (2) activation of duodenal vagal af
16 (60 nl)(-1)) in mNTS produced inhibition of gastric motility and an increase in intragastric pressur
20 18 mmHg) provoked a significant reduction in gastric motility and tone recorded with strain gauges.
21 est that glucoprivation-induced increases in gastric motility are dependent on intact hindbrain astro
27 l for each site) of CRF in the DVC decreased gastric motility in rats pretreated with the muscarinic
28 iew focuses on progress made in the field of gastric motility in the past year, emphasizing advances
31 relationship between utilizable nutrient and gastric motility is well recognized, the explanation of
32 tion of CRF(2) receptors and the decrease in gastric motility observed following microinjection of CR
33 contractility; electrical activity; regional gastric motility of the fundus, antrum, and pylorus; and
34 tion in critically ill adults; however, poor gastric motility often prevents nutritional targets bein
35 tiology is likely multifactorial, related to gastric motility, respiratory secretions, and medication
36 ed by thyrotrophin-releasing hormone and the gastric motility response to DMV microinjections of TRH
37 tion of gastroparesis and other disorders of gastric motility; Society of Nuclear Medicine and Molecu
39 ring GES can yield additional information on gastric motility to help explain patients' symptoms.
40 wnstream NST neurons that, in turn, suppress gastric motility via action on neurons in the dorsal mot
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。